Please assess the completion status of the following clinical trial:

Trial Title: A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Negative rapid diagnostic test for influenza at baseline;~* Immunocompromised participant (liver and/or kidney recipient or allogenic hematopoietic stem cell transplant).~Exclusion Criteria:~* Symptoms suggestive of influenza-like illness; but not limited to fever, cough, or nasal congestion;~* Influenza vaccination in 6 weeks prior to randomization;~* Positive rapid diagnostic test for influenza;~* Solid organ transplant within 6 months of randomization;~* Antiviral treatment for influenza in 2 weeks prior to randomization.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oseltamivir (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).